{"chebi_id":"9168","chebi_name":"sirolimus","chebi_synonyms":["(-)-Rapamycin","Antibiotic AY 22989","Sirolimus","Rapamune","(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone","sirolim\u00fas","sirolimusum","(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone","rapamycin"],"diffprof_id_observed":["MTBLS379_0001_00000001","MTBLS379_0002_00000001","MTBLS5943_0001_00000001"],"diffprof_id_var_observed":[],"inchikey":"QFJCIRLUMZQUOT-HPLJOQBZSA-N","inn_name":"sirolimus","iupac_name":"(3<i>S</i>,6<i>R</i>,7<i>E</i>,9<i>R</i>,10<i>R</i>,12<i>R</i>,14<i>S</i>,15<i>E</i>,17<i>E</i>,19<i>E</i>,21<i>S</i>,23<i>S</i>,26<i>R</i>,27<i>R</i>,34a<i>S</i>)-9,27-dihydroxy-3-{(2<i>R</i>)-1-[(1<i>S</i>,3<i>R</i>,4<i>R</i>)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3<em>H</em>-23,27-epoxypyrido[2,1-<em>c</em>][1,4]oxazacyclohentriacontine-1,5,11,28,29(4<em>H</em>,6<em>H</em>,31<em>H</em>)-pentone","num_study_observed":2,"reactome_ids":["R-HSA-162582","R-HSA-1643685","R-HSA-165159","R-HSA-166208","R-HSA-5663205","R-HSA-9679191","R-HSA-9679506","R-HSA-9824446"],"reactome_names":["Signal Transduction","Disease","MTOR signalling","mTORC1-mediated signalling","Infectious disease","Potential therapeutics for SARS","SARS-CoV Infections","Viral Infection Pathways"],"study_id_observed":["MTBLS379","MTBLS5943"],"study_id_var_observed":[],"synonym_name":"(-)-Rapamycin"}